Bionomics Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Spyros Papapetropoulos

Chief executive officer

AU$919.8k

Total compensation

CEO salary percentage52.2%
CEO tenure1.3yrs
CEO ownershipn/a
Management average tenureless than a year
Board average tenure3.2yrs

Recent management updates

Recent updates

We're Keeping An Eye On Bionomics' (NASDAQ:BNOX) Cash Burn Rate

Sep 29
We're Keeping An Eye On Bionomics' (NASDAQ:BNOX) Cash Burn Rate

Bionomics receives R&D tax incentive refund for FY22 of A$4.6M

Oct 18

CEO Compensation Analysis

How has Spyros Papapetropoulos's remuneration changed compared to Bionomics's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023n/an/a

-AU$31m

Sep 30 2023n/an/a

-AU$31m

Jun 30 2023AU$920kAU$480k

-AU$32m

Compensation vs Market: Spyros's total compensation ($USD615.89K) is about average for companies of similar size in the US market ($USD661.60K).

Compensation vs Earnings: Insufficient data to compare Spyros's compensation with company performance.


CEO

Spyros Papapetropoulos (50 yo)

1.3yrs

Tenure

AU$919,771

Compensation

Dr. Spyridon Papapetropoulos, M. D., Ph. D., also known as Spyros, serves as Director, President & Chief Executive Officer at Bionomics Limited from January 05, 2023. He served as Member of Scientific Advi...


Leadership Team

NamePositionTenureCompensationOwnership
Spyridon Papapetropoulos
CEO, President & Director1.3yrsAU$919.77kno data
Adrian Hinton
Financial Controllerless than a yearAU$299.55k0.0037%
A$ 354.1
Timothy Cunningham
Chief Financial Officerless than a yearno datano data
Paul Rolan
Consultant Chief Medical Officer of Clinical Neuroscienceno dataAU$102.00kno data
Julie Kerner
Senior Vice President of Business Operationsless than a yearno datano data
Suzanne Irwin
Company Secretary3.1yrsno datano data

1.0yrs

Average Tenure

60yo

Average Age

Experienced Management: BNOX's management team is not considered experienced ( 1 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Spyridon Papapetropoulos
CEO, President & Director1.3yrsAU$919.77kno data
David Wilson
Independent Non-Executive Director7.9yrsAU$87.00k0.013%
A$ 1.3k
Alan Fisher
Independent Non-Executive Chair of the Board7.7yrsAU$87.00k0.0052%
A$ 505.6
Jane Ryan
Independent Non-Executive Director3.6yrsAU$86.72k0%
A$ 0
Srinivas Rao
Member of Clinical Advisory Board2.6yrsAU$57.75kno data
Murray Stein
Member of Clinical Advisory Boardno datano datano data
Steven Williams
Scientific Advisorno datano datano data
Allan Young
Scientific Advisorno datano datano data
Marina Picciotto
Scientific Advisorno datano datano data
Peter Miles Davies
Independent Non-Executive Director2.8yrsAU$77.00k0.014%
A$ 1.4k
Aaron N. Weaver
Independent Non-Executive Nominee Director3.8yrsAU$77.00kno data
Michael Gendreau
Member of Clinical Advisory Board2.6yrsno datano data

3.2yrs

Average Tenure

54yo

Average Age

Experienced Board: BNOX's board of directors are considered experienced (3.2 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.